Dualyx
Dualyx is a clinical-stage treatment of autoimmune and rare diseases founded in 2021.
1
Funding Rounds
$43.0m
Money raised
Overview
Dualyx is a clinical-stage treatment of autoimmune and rare diseases founded in 2021.
- Website:
- Headquarters: Ghent
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Dualyx has raised a total of $43m in funding over 1 rounds.
Key Insights:
- Dualyx May 2023 Series A Funding Round: $43m
Dualyx May 2023 Series A Funding Round
$43m